CPI-1189 is an orally active TNF-alpha release inhibitor. CPI-1189 inhibits phosphorylation of p38. CPI-1189 can inhibit apoptosis. CPI-1189 can be used in the study of HIV and neurological diseases[1][2][3][4][5].
Molecular Weight:
234.30
Purity:
99.82
CAS Number:
[183619-38-7]
Formula:
C13H18N2O2
Target:
Apoptosis,TNF Receptor
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted